Improving Transparency and Speed of Prior Authorizations
Medicare Doubles Down on Restricting New Alzheimer’s Meds
Legislating Access to Serious Mental Illness Treatments
Limiting Access to Obesity Care Is Not an Effective or Humane Approach to Cost Management
RSV Vaccine to Get Priority Review by the FDA
Access to Care Shouldn’t be Rare
FDA Grants Priority Review to Drug for Depressive Disorders
Racial Disparities Still Haunt Progress Against CVD
COVID-19 Continues to Challenge People Living with Headache
New Paper Identifies Key Challenges for Providers Treating Mental Health
